Template:B-cell prolymphocytic leukemia: Difference between revisions

Jump to navigation Jump to search
Carlos Lopez (talk | contribs)
No edit summary
Carlos Lopez (talk | contribs)
No edit summary
Line 159: Line 159:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma surgery|Surgery]]
[[B-cell prolymphocytic leukemia surgery|Surgery]]
|-  
|-  
!
!
Line 165: Line 165:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[B-cell prolymphocytic leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 171: Line 171:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma future or investigational therapies|Future or Investigational Therapies]]
[[B-cell prolymphocytic leukemia future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
Line 183: Line 183:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma case study one|Case #1]]
[[B-cell prolymphocytic leukemia case study one|Case #1]]
|-  
|-  
!
!

Revision as of 14:31, 5 October 2015